Brown KF, et al.
Factors underlying parental decisions about combination childhood vaccinations including MMR: a systematic review. Vaccine
2010; 28: 4235–4248.
Lamden KH, Gemmell I. General practice factors and MMR vaccine uptake: structure, process and demography. Journal of Public Health
2008; 30: 251–257.
Pearce A, et al.
Factors associated with uptake of measles, mumps, and rubella vaccine (MMR) and use of single antigen vaccines in a contemporary UK cohort: prospective cohort study. British Medical Journal
2008; 336: 754–757.
Wakefield AJ, et al.
Retracted: Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet
1998; 351: 637–641.
Friederichs V, Cameron JC, Robertson C. Impact of adverse publicity on MMR vaccine uptake: a population based analysis of vaccine uptake records for one million children, born 1987–2004. Archives of Disease in Childhood
2006; 91: 465–468.
Chen RT, DeStefano F. Vaccine adverse events: causal or coincidental?
1998; 351: 611–612.
Nicoll A, Elliman D, Ross E. MMR vaccination and autism 1998. British Medical Journal
1998; 316: 715–716.
Bower H. MMR vaccine policy is backed. British Medical Journal
1998; 316: 955.
Metcalf J. Is measles infection associated with Crohn's disease?
British Medical Journal
1998; 316: 166.
Fombonne E. Inflammatory bowel disease and autism. Lancet
1998; 351: 955.
Patja A, et al.
Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatric Infectious Disease Journal
2000; 19: 1127–1134.
Peltola H, et al.
No evidence for measles, mumps, and rubella vaccine-associated inflammatory bowel disease or autism in a 14-year prospective study. Lancet
1998; 351: 1327–1328.
Kaye JA, Melero-Montes MdM, Jick H. Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. British Medical Journal
2001; 322: 460–463.
Taylor B, et al.
Autism and measles, mumps, and rubella vaccine: no epidemiological evidence for a causal association. Lancet
1999; 353: 2026–2029.
Taylor B, et al.
Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. British Medical Journal
2002; 324: 393–396.
Vivancos R, et al.
An ongoing large outbreak of measles in Merseyside, England, January to June 2012. Eurosurveillance
Alfredsson R, et al.
Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
2004; 93: 1232–1237.
Bardenheier B, et al.
Are parental vaccine safety concerns associated with receipt of measles-mumps-rubella, diphtheria and tetanus toxoids with acellular pertussis, or hepatitis b vaccines by children?
Archives of Pediatrics and Adolescent Medicine
2004; 158: 569–575.
Casiday R, et al.
A survey of UK parental attitudes to the MMR vaccine and trust in medical authority. Vaccine
2006; 24: 177–184.
Gellatly J, McVittie C, Tiliopoulos N. Predicting parents' decisions on MMR immunisation: a mixed method investigation. Family Practice
2005; 22: 658–662.
Cassell JA, et al.
Is the cultural context of MMR rejection a key to an effective public health discourse?
2006; 120: 783–794.
Mills E, et al.
Systematic review of qualitative studies exploring parental beliefs and attitudes toward childhood vaccination identifies common barriers to vaccination. Journal of Clinical Epidemiology
2005; 58: 1081–1088.
Le Menach A, et al.
Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England. Vaccine
2014; 32: 1147–1152.
Paranthaman K, Bunce A. Opportunistic MMR vaccination for unimmunized children at the time of routine teenage booster vaccination in secondary schools: implications for policy. Epidemiology and Infection
2012; 140: 1612–1616.
Nyhan B, et al.
Effective messages in vaccine promotion: a randomized trial. Pediatrics
2014; 133: 835–842.
Jackson C, et al.
Randomised cluster trial to support informed parental decision-making for the MMR vaccine. BMC Public Health
2011; 11: 475.
McMurray R, et al.
Managing controversy through consultation: a qualitative study of communication and trust around MMR vaccination decisions. British Journal of General Practice
2004; 54: 520–525.
Brown KF, et al.
U.K. parents' decision-making about measles-mumps-rubella (MMR) vaccine 10 years after the MMR-autism controversy: a qualitative analysis. Vaccine
2012; 30: 1855–1864.
Samad L, et al.
Incomplete immunisation uptake in infancy: maternal reasons. Vaccine
2006; 24: 6823–6829.